Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
07/2003
07/02/2003EP1322629A1 Tetrahydrofuran derivatives and their use as nk-1 antagonists
07/02/2003EP1322628A2 Substituted urea neuropeptide y y5 receptor antagonists
07/02/2003EP1322623A2 Hydroxy acid integrin antagonists
07/02/2003EP1322620A1 Benzimidazole and indole derivatives as crf receptor modulators
07/02/2003EP1322617A1 Compounds and methods for modulation of estrogen receptors
07/02/2003EP1322616A2 Quinoline-(c=o)-(di-, tri- and tetrapeptide) derivatives as caspase inhibitors
07/02/2003EP1322613A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
07/02/2003EP1322596A1 Zwitterionic tachykinin receptor antagonists
07/02/2003EP1322593A1 O-substituted 6-methyl-tramadol derivatives
07/02/2003EP1322592A1 Substituted 1-aminobutan-3-ol derivatives
07/02/2003EP1322383A2 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
07/02/2003EP1322338A2 Compositions and methods of using capsid protein from flaviviruses and pestiviruses
07/02/2003EP1322327A1 Stabilisation of plasmid inheritance in bacteria by preventing multimerisation
07/02/2003EP1322318A1 Use of probiotic lactic acid bacteria for balancing the skin's immune system
07/02/2003EP1322309A2 High affinity small molecule c5a receptor modulators
07/02/2003EP1322306A2 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
07/02/2003EP1322288A1 Inducing cellular immune responses to hepatitis b virus using peptide and nucleic acid compositions
07/02/2003EP1224180B1 Substituted azoles
07/02/2003EP1218372B1 Novel heterocyclic compounds useful as reversible inhibitors of cysteine proteases
07/02/2003EP1210346B1 New active marine alkaloids
07/02/2003EP1181290B1 Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions
07/02/2003EP1171444B1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
07/02/2003EP1150666A4 Stimulating neutrophil function to treat inflammatory bowel disease
07/02/2003EP1124539B1 Pharmaceutical formulation comprising omeprazole
07/02/2003EP1028954B1 Substituted imidazoles useful in the treatment of inflammatory diseases
07/02/2003EP0975327B1 Use of 5ht3 antagonists for promoting intestinal lavage
07/02/2003EP0900211B1 Thiadiazolyl(thio)ureas useful as matrix metalloprotease inhibitors
07/02/2003EP0732875B1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
07/02/2003CN1427837A Ortho-substituted anthranilic acid amides and their use as medicaments
07/02/2003CN1427826A Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl IV, processes for their preparation, and their use
07/02/2003CN1427724A Irradiation of ispaghula
07/02/2003CN1427723A Composition for treatment of B-type hepatitis and liver cirrhosis
07/02/2003CN1427719A Use of substituted acryloyl distamycin derivatives in treatment of tumors associated with high levels of glutathione
07/02/2003CN1426812A Relaxation of Climacteric syndrome by using antisenility action of glossy ganoderma
07/02/2003CN1426810A Anti alcoholic agent using alder as material and mfg. method thereof
07/02/2003CN1426797A Chinese medicinal preparation for treating chronic colonitis and its preparation method
07/02/2003CN1426790A Forest frog oil soft capsule
07/02/2003CN1426789A Sterculia frost flower lozenge and its preparation method
07/02/2003CN1426785A Chinese medicinal herbs prescription for treating hepatitis B
07/02/2003CN1113059C Pipeazino derivatives as neurokinin antagonists
07/02/2003CN1113057C Quinoline derivatives
07/02/2003CN1112932C Antidiarrheal
07/02/2003CN1112923C Indazole carboxamides
07/01/2003US6586474 Amidino compounds useful as nitric oxide synthase inhibitors
07/01/2003US6586471 Halogenated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
07/01/2003US6586456 Corticotropin releasing factor (CRF) antagonists such as (4-(2-chloro-4-methoxy-5-methylphenyl)-5-methylthiazol-2-yl)(( (1-(3-fluoro-4-methylphenyl)-2-methoxyethyl))prop-2-ynylamine, prepared by alkylation with propagyl bromide
07/01/2003US6586445 Racemic mixtures of 1,2,3,4-tetra hydro-1-(4-methoxyphenyl)-3 -(4-phenyl-1H-imidazol-2-yl)-9H- pyrido(3,4-b)indole, which bind to somatostatin receptors and block sodium channel modulators; antidiabetic, antiinflammatory agents; diarrhea
07/01/2003US6586436 Serotonergic agents
07/01/2003US6586432 Neurokinin-1 receptor antagonists
07/01/2003US6586431 3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives
07/01/2003US6586429 For treatment of chronic inflammatory disease, chronic intestinalinflammation, arthritis, psoriasis, asthma, autoimmune disorders
07/01/2003US6586428 Combined preparations comprising morpholine anthracyclines and anticancer agent
07/01/2003US6586422 Pyrazine and triazine derivatives of 1,2,4,5-tetrahydro-Benzo or Thieno [d] azepine
07/01/2003US6586227 Non-virulent Porphyromonas gingivalis mutant
07/01/2003US6586022 Containing dry powder of root of peony; side effect reduction
07/01/2003US6586015 Use of Phyllanthus for treating chronic inflammatory and fibrotic processes
07/01/2003US6585977 Non-virulent Porphyromonas gingivalis mutant
07/01/2003US6585974 Preventives for hepatopathy
07/01/2003CA2080548C Monoclonal antibodies to hepatitis c virus
06/2003
06/26/2003WO2003052412A2 Diagnosis of inflammatory bowel disease
06/26/2003WO2003052089A1 Disruption of the glutathione s-transferase-omega-1 gene
06/26/2003WO2003052051A2 Adeno-associated virus (aav) serotype 8 sequences
06/26/2003WO2003052048A2 Nucleic acid-associated proteins
06/26/2003WO2003051917A2 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
06/26/2003WO2003051912A2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
06/26/2003WO2003051890A1 Imidazo [2,1-b]-1,3,4-thiadiazole suflonamides
06/26/2003WO2003051888A1 6-aminomorphinane derivatives, method for the production and use thereof
06/26/2003WO2003051885A1 Nitrogen-containing heterocyclic compounds and use thereof
06/26/2003WO2003051884A1 Fused indole compound, process for producing the same, and use
06/26/2003WO2003051878A1 Quinolinones as prostaglandin receptor ligands
06/26/2003WO2003051876A1 Pyrazolopyridine derivatives and medicinal use thereof
06/26/2003WO2003051872A1 Ethylene diamine derivatives and their use as orexin-receptor antagonists
06/26/2003WO2003051869A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives
06/26/2003WO2003051868A1 Lactams as tachykinin antagonists
06/26/2003WO2003051867A1 New process
06/26/2003WO2003051863A1 SUBSTITUTED 6H-DIBENZO[c,h]CHROMENES AS ESTROGENIC AGENTS
06/26/2003WO2003051855A1 N,n'-disubstituted piperazine compounds and the use of the same as analgesics
06/26/2003WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051840A1 Pyrrolidine and piperidine derivates as nk1 antagonists
06/26/2003WO2003051828A2 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
06/26/2003WO2003051825A1 Human adam-10 inhibitors
06/26/2003WO2003051819A1 Substituted 1,5-diaminopentan-3-ol compounds
06/26/2003WO2003051805A2 Substituted phenyl naphthalenes as estrogenic agents
06/26/2003WO2003051373A1 Liquid bisphosphonate formulations for bone disorders
06/26/2003WO2003051372A1 Methods for treatment or prophylaxis of aldosterone-mediated pathogenic effectgs in a subject using an epoxy-steroidal aldosterone antagonist
06/26/2003WO2003051369A1 Pharmaceutical containing n, n'-disubstituted piperazine compounds
06/26/2003WO2003051365A2 Use of compounds of the benzamide family as immunosuppressant
06/26/2003WO2003051361A1 Use of hiv-1 protease inhibitors and their derivatives in the treatment of inflammation
06/26/2003WO2003051358A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/26/2003WO2003051353A1 Substituted beta-aminoalcohols used as medicaments
06/26/2003WO2003051345A2 Use of digestive enzyme mixtures for treating pathological bacterial overgrowth of the small intestine of mammals and humans
06/26/2003WO2003051342A1 Compressed oral pharmaceutical dosage form, with an enteric coating, which contains an acid-labile benzimidazole compound
06/26/2003WO2003051333A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
06/26/2003WO2003051306A2 N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections
06/26/2003WO2003051287A2 Topical compositions and methods for treatment of adverse effects of ionizing radiation
06/26/2003WO2003051277A2 Novel compounds
06/26/2003WO2003051274A2 Benzodiazepine derivatives, preparation thereof and use thereof
06/26/2003WO2002098352A3 PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs
06/26/2003WO2002094202A3 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules
1 ... 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 ... 1258